USJ Stock Chart & Stats
€19.50
-€0.50(-2.50%)
At close: 4:00 PM EDT
€19.50
-€0.50(-2.50%)
Day’s Range― - ―
52-Week Range€14.10 - €27.20
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€354.80M
Enterprise Value€213.63
Total Cash (Recent Filing)€162.75M
Total Debt (Recent Filing)€14.00M
Price to Earnings (P/E)46.7
Beta0.75
Next Earnings
Aug 04, 2026EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding18,463,010
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.85
Revenue Forecast (FY)€820.87M
Bulls Say, Bears Say
Bulls Say
High Gross Margin & Revenue RecoveryHigh gross margins (~77%) combined with a return to modest TTM revenue growth (+7.3%) indicate durable product economics and healthier demand. Strong unit economics on consumable nutrition products support reinvestment capacity and provide a structural base for margin recovery as scale improves.
Conservative Balance SheetVery low leverage (debt-to-equity ~0.03) gives the company meaningful financial flexibility and lowers refinancing and interest risk. This conservatism supports continued investments (ERP, manufacturing, inventory) during the multi‑year omnichannel transition without materially increasing financial distress risk.
Omni-channel & Rise Wellness TractionRapid Rise Wellness growth and omnichannel momentum (Rise $14M Q1; omni share targeting >20% in 2026) diversify revenue beyond legacy direct selling. National retail placements (Costco, Target, Walmart) create scalable distribution, broaden acquisition channels, and reduce single-channel dependency over the medium term.
Bears Say
Compressed ProfitabilityNet margin compression to roughly 1.0% TTM indicates materially reduced earnings power despite revenue stabilization. Lower margins diminish the company's ability to self-fund growth initiatives, cushion shocks, or restore ROE, making durable profitability recovery reliant on successful cost and channel optimization.
Weak Cash GenerationModest operating cash flow and very low free cash flow (~$3.0M) constrain financial flexibility for working capital, retail inventory builds, and marketing investments. Sustained low cash conversion increases reliance on liquidity buffers or external funding and limits the firm's ability to pursue opportunistic investments or return capital.
Elevated Customer Acquisition Costs (HYA)Elevated CAC and higher SG&A for HYA as it expands internationally and into retail pressure near-term unit economics. Because HYA is still early-stage, profitability hinges on achieving scale and sustainably lower CAC; prolonged elevated acquisition costs could delay margin realization and strain cash needs.
USANA Health News
USJ FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was €14.10 and its highest was €27.20 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is €354.80M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Aug 04, 2026 which is in 2 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on May 05, 2026. The company reported €0.533 earnings per share for the quarter, beating the consensus estimate of €0.384 by €0.148.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.38.
How many shares outstanding does USANA Health have?
USANA Health has 18,463,010 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of €0.533 in its last earnings report, beating expectations of €0.384. Following the earnings report the stock price went up 1.899%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in DE:USJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:USJ Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $619.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USJ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful progress across multiple strategic priorities: sequential recovery in the core nutritional business, strong acceleration and retail traction for Rise Wellness, and international and retail expansion for HYA alongside operational integrations and a sizable R&D pipeline. Near-term pressures include higher customer acquisition costs (HYA), increased SG&A, cash used to support initial retail inventory (Costco), and some uncertainty around retailer cadence and macro risks. On balance, the positive operational momentum, reaffirmed guidance ($925M–$1.0B) and advancing omni-channel mix outweigh the contained near-term costs and risks.View all DE:USJ earnings summariesTechnical Analysis
Herbalife
―
Lifeway Foods
―
Nature's Sunshine Products
―
LifeVantage
―
FitLife Brands
―